0.008853 0.000000 0.002347 0.000000 0.025969 0.000000 0.000000 0.000000 0.011634 0.00000 0.00000 0.00000 Abrahams, J.P. Elliott, P.R. Lomas, D.A. Carrell, R.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 104.85 90.00 112.958 38.508 88.928 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C5 H11 N O2 S2 181.276 n 3-(ethyldisulfanyl)-L-alanine L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 3 676 681 10.1038/nsb0896-676 8756325 Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. 1996 10.2210/pdb1psi/pdb pdb_00001psi 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 NICKEL COATED DOUBLE MIRROR IMAGE PLATE 1996-02-12 MARRESEARCH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE ELLIOTT GX-11 44406.539 ALPHA=1=-ANTITRYPSIN F51L 1 man polymer no yes MDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIATAFAMLSLGTKADTHDEILEGL NFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDY VEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQH(SCS)KKLS SWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGA DLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK MDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIATAFAMLSLGTKADTHDEILEGL NFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDY VEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVL LMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSG VTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo BLOOD PLASMA Escherichia sample ALPHA-1-ANTITRYPSIN 9606 BLOOD Homo sapiens ALPHA-1-ANTITRYPSIN 562 Escherichia coli PTERMAT 1 2.11 45.00 6.0 24% PEG, 0.2 M SODIUM ACETATE, 0.1 M TRIS.HCL, PH 6.0, 0.002 M FESO4, 25 DEG CELSIUS database_2 pdbx_database_status struct_conn struct_ref_seq_dif struct_sheet pdbx_initial_refinement_model repository Initial release Version format compliance Version format compliance Database references Derived calculations Other Refinement description 1 0 1996-12-07 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 1 4 2023-08-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details _struct_sheet.number_strands Y BNL 1996-06-11 REL REL 9API CLEAVED ALPHA1-ANTITRYPSIN (PDB ENTRY 9API) PDB experimental model n 1 1 A n 2 2 A n 3 3 A n 4 4 A n 5 5 A n 6 6 A n 7 7 A n 8 8 A n 9 9 A n 10 10 A n 11 11 A n 12 12 A n 13 13 A n 14 14 A n 15 15 A n 16 16 A n 17 17 A n 18 18 A n 19 19 A n 20 20 A n 21 21 A n 22 22 A PHE 23 n 23 PHE 23 A ASN 24 n 24 ASN 24 A LYS 25 n 25 LYS 25 A ILE 26 n 26 ILE 26 A THR 27 n 27 THR 27 A PRO 28 n 28 PRO 28 A ASN 29 n 29 ASN 29 A LEU 30 n 30 LEU 30 A ALA 31 n 31 ALA 31 A GLU 32 n 32 GLU 32 A PHE 33 n 33 PHE 33 A ALA 34 n 34 ALA 34 A PHE 35 n 35 PHE 35 A SER 36 n 36 SER 36 A LEU 37 n 37 LEU 37 A TYR 38 n 38 TYR 38 A ARG 39 n 39 ARG 39 A GLN 40 n 40 GLN 40 A LEU 41 n 41 LEU 41 A ALA 42 n 42 ALA 42 A HIS 43 n 43 HIS 43 A GLN 44 n 44 GLN 44 A SER 45 n 45 SER 45 A ASN 46 n 46 ASN 46 A SER 47 n 47 SER 47 A THR 48 n 48 THR 48 A ASN 49 n 49 ASN 49 A ILE 50 n 50 ILE 50 A LEU 51 n 51 LEU 51 A PHE 52 n 52 PHE 52 A SER 53 n 53 SER 53 A PRO 54 n 54 PRO 54 A VAL 55 n 55 VAL 55 A SER 56 n 56 SER 56 A ILE 57 n 57 ILE 57 A ALA 58 n 58 ALA 58 A THR 59 n 59 THR 59 A ALA 60 n 60 ALA 60 A PHE 61 n 61 PHE 61 A ALA 62 n 62 ALA 62 A MET 63 n 63 MET 63 A LEU 64 n 64 LEU 64 A SER 65 n 65 SER 65 A LEU 66 n 66 LEU 66 A GLY 67 n 67 GLY 67 A THR 68 n 68 THR 68 A LYS 69 n 69 LYS 69 A ALA 70 n 70 ALA 70 A ASP 71 n 71 ASP 71 A THR 72 n 72 THR 72 A HIS 73 n 73 HIS 73 A ASP 74 n 74 ASP 74 A GLU 75 n 75 GLU 75 A ILE 76 n 76 ILE 76 A LEU 77 n 77 LEU 77 A GLU 78 n 78 GLU 78 A GLY 79 n 79 GLY 79 A LEU 80 n 80 LEU 80 A ASN 81 n 81 ASN 81 A PHE 82 n 82 PHE 82 A ASN 83 n 83 ASN 83 A LEU 84 n 84 LEU 84 A THR 85 n 85 THR 85 A GLU 86 n 86 GLU 86 A ILE 87 n 87 ILE 87 A PRO 88 n 88 PRO 88 A GLU 89 n 89 GLU 89 A ALA 90 n 90 ALA 90 A GLN 91 n 91 GLN 91 A ILE 92 n 92 ILE 92 A HIS 93 n 93 HIS 93 A GLU 94 n 94 GLU 94 A GLY 95 n 95 GLY 95 A PHE 96 n 96 PHE 96 A GLN 97 n 97 GLN 97 A GLU 98 n 98 GLU 98 A LEU 99 n 99 LEU 99 A LEU 100 n 100 LEU 100 A ARG 101 n 101 ARG 101 A THR 102 n 102 THR 102 A LEU 103 n 103 LEU 103 A ASN 104 n 104 ASN 104 A GLN 105 n 105 GLN 105 A PRO 106 n 106 PRO 106 A ASP 107 n 107 ASP 107 A SER 108 n 108 SER 108 A GLN 109 n 109 GLN 109 A LEU 110 n 110 LEU 110 A GLN 111 n 111 GLN 111 A LEU 112 n 112 LEU 112 A THR 113 n 113 THR 113 A THR 114 n 114 THR 114 A GLY 115 n 115 GLY 115 A ASN 116 n 116 ASN 116 A GLY 117 n 117 GLY 117 A LEU 118 n 118 LEU 118 A PHE 119 n 119 PHE 119 A LEU 120 n 120 LEU 120 A SER 121 n 121 SER 121 A GLU 122 n 122 GLU 122 A GLY 123 n 123 GLY 123 A LEU 124 n 124 LEU 124 A LYS 125 n 125 LYS 125 A LEU 126 n 126 LEU 126 A VAL 127 n 127 VAL 127 A ASP 128 n 128 ASP 128 A LYS 129 n 129 LYS 129 A PHE 130 n 130 PHE 130 A LEU 131 n 131 LEU 131 A GLU 132 n 132 GLU 132 A ASP 133 n 133 ASP 133 A VAL 134 n 134 VAL 134 A LYS 135 n 135 LYS 135 A LYS 136 n 136 LYS 136 A LEU 137 n 137 LEU 137 A TYR 138 n 138 TYR 138 A HIS 139 n 139 HIS 139 A SER 140 n 140 SER 140 A GLU 141 n 141 GLU 141 A ALA 142 n 142 ALA 142 A PHE 143 n 143 PHE 143 A THR 144 n 144 THR 144 A VAL 145 n 145 VAL 145 A ASN 146 n 146 ASN 146 A PHE 147 n 147 PHE 147 A GLY 148 n 148 GLY 148 A ASP 149 n 149 ASP 149 A THR 150 n 150 THR 150 A GLU 151 n 151 GLU 151 A GLU 152 n 152 GLU 152 A ALA 153 n 153 ALA 153 A LYS 154 n 154 LYS 154 A LYS 155 n 155 LYS 155 A GLN 156 n 156 GLN 156 A ILE 157 n 157 ILE 157 A ASN 158 n 158 ASN 158 A ASP 159 n 159 ASP 159 A TYR 160 n 160 TYR 160 A VAL 161 n 161 VAL 161 A GLU 162 n 162 GLU 162 A LYS 163 n 163 LYS 163 A GLY 164 n 164 GLY 164 A THR 165 n 165 THR 165 A GLN 166 n 166 GLN 166 A GLY 167 n 167 GLY 167 A LYS 168 n 168 LYS 168 A ILE 169 n 169 ILE 169 A VAL 170 n 170 VAL 170 A ASP 171 n 171 ASP 171 A LEU 172 n 172 LEU 172 A VAL 173 n 173 VAL 173 A LYS 174 n 174 LYS 174 A GLU 175 n 175 GLU 175 A LEU 176 n 176 LEU 176 A ASP 177 n 177 ASP 177 A ARG 178 n 178 ARG 178 A ASP 179 n 179 ASP 179 A THR 180 n 180 THR 180 A VAL 181 n 181 VAL 181 A PHE 182 n 182 PHE 182 A ALA 183 n 183 ALA 183 A LEU 184 n 184 LEU 184 A VAL 185 n 185 VAL 185 A ASN 186 n 186 ASN 186 A TYR 187 n 187 TYR 187 A ILE 188 n 188 ILE 188 A PHE 189 n 189 PHE 189 A PHE 190 n 190 PHE 190 A LYS 191 n 191 LYS 191 A GLY 192 n 192 GLY 192 A LYS 193 n 193 LYS 193 A TRP 194 n 194 TRP 194 A GLU 195 n 195 GLU 195 A ARG 196 n 196 ARG 196 A PRO 197 n 197 PRO 197 A PHE 198 n 198 PHE 198 A GLU 199 n 199 GLU 199 A VAL 200 n 200 VAL 200 A LYS 201 n 201 LYS 201 A ASP 202 n 202 ASP 202 A THR 203 n 203 THR 203 A GLU 204 n 204 GLU 204 A GLU 205 n 205 GLU 205 A GLU 206 n 206 GLU 206 A ASP 207 n 207 ASP 207 A PHE 208 n 208 PHE 208 A HIS 209 n 209 HIS 209 A VAL 210 n 210 VAL 210 A ASP 211 n 211 ASP 211 A GLN 212 n 212 GLN 212 A VAL 213 n 213 VAL 213 A THR 214 n 214 THR 214 A THR 215 n 215 THR 215 A VAL 216 n 216 VAL 216 A LYS 217 n 217 LYS 217 A VAL 218 n 218 VAL 218 A PRO 219 n 219 PRO 219 A MET 220 n 220 MET 220 A MET 221 n 221 MET 221 A LYS 222 n 222 LYS 222 A ARG 223 n 223 ARG 223 A LEU 224 n 224 LEU 224 A GLY 225 n 225 GLY 225 A MET 226 n 226 MET 226 A PHE 227 n 227 PHE 227 A ASN 228 n 228 ASN 228 A ILE 229 n 229 ILE 229 A GLN 230 n 230 GLN 230 A HIS 231 n 231 HIS 231 A SCS 232 n 232 SCS 232 A LYS 233 n 233 LYS 233 A LYS 234 n 234 LYS 234 A LEU 235 n 235 LEU 235 A SER 236 n 236 SER 236 A SER 237 n 237 SER 237 A TRP 238 n 238 TRP 238 A VAL 239 n 239 VAL 239 A LEU 240 n 240 LEU 240 A LEU 241 n 241 LEU 241 A MET 242 n 242 MET 242 A LYS 243 n 243 LYS 243 A TYR 244 n 244 TYR 244 A LEU 245 n 245 LEU 245 A GLY 246 n 246 GLY 246 A ASN 247 n 247 ASN 247 A ALA 248 n 248 ALA 248 A THR 249 n 249 THR 249 A ALA 250 n 250 ALA 250 A ILE 251 n 251 ILE 251 A PHE 252 n 252 PHE 252 A PHE 253 n 253 PHE 253 A LEU 254 n 254 LEU 254 A PRO 255 n 255 PRO 255 A ASP 256 n 256 ASP 256 A GLU 257 n 257 GLU 257 A GLY 258 n 258 GLY 258 A LYS 259 n 259 LYS 259 A LEU 260 n 260 LEU 260 A GLN 261 n 261 GLN 261 A HIS 262 n 262 HIS 262 A LEU 263 n 263 LEU 263 A GLU 264 n 264 GLU 264 A ASN 265 n 265 ASN 265 A GLU 266 n 266 GLU 266 A LEU 267 n 267 LEU 267 A THR 268 n 268 THR 268 A HIS 269 n 269 HIS 269 A ASP 270 n 270 ASP 270 A ILE 271 n 271 ILE 271 A ILE 272 n 272 ILE 272 A THR 273 n 273 THR 273 A LYS 274 n 274 LYS 274 A PHE 275 n 275 PHE 275 A LEU 276 n 276 LEU 276 A GLU 277 n 277 GLU 277 A ASN 278 n 278 ASN 278 A GLU 279 n 279 GLU 279 A ASP 280 n 280 ASP 280 A ARG 281 n 281 ARG 281 A ARG 282 n 282 ARG 282 A SER 283 n 283 SER 283 A ALA 284 n 284 ALA 284 A SER 285 n 285 SER 285 A LEU 286 n 286 LEU 286 A HIS 287 n 287 HIS 287 A LEU 288 n 288 LEU 288 A PRO 289 n 289 PRO 289 A LYS 290 n 290 LYS 290 A LEU 291 n 291 LEU 291 A SER 292 n 292 SER 292 A ILE 293 n 293 ILE 293 A THR 294 n 294 THR 294 A GLY 295 n 295 GLY 295 A THR 296 n 296 THR 296 A TYR 297 n 297 TYR 297 A ASP 298 n 298 ASP 298 A LEU 299 n 299 LEU 299 A LYS 300 n 300 LYS 300 A SER 301 n 301 SER 301 A VAL 302 n 302 VAL 302 A LEU 303 n 303 LEU 303 A GLY 304 n 304 GLY 304 A GLN 305 n 305 GLN 305 A LEU 306 n 306 LEU 306 A GLY 307 n 307 GLY 307 A ILE 308 n 308 ILE 308 A THR 309 n 309 THR 309 A LYS 310 n 310 LYS 310 A VAL 311 n 311 VAL 311 A PHE 312 n 312 PHE 312 A SER 313 n 313 SER 313 A ASN 314 n 314 ASN 314 A GLY 315 n 315 GLY 315 A ALA 316 n 316 ALA 316 A ASP 317 n 317 ASP 317 A LEU 318 n 318 LEU 318 A SER 319 n 319 SER 319 A GLY 320 n 320 GLY 320 A VAL 321 n 321 VAL 321 A THR 322 n 322 THR 322 A GLU 323 n 323 GLU 323 A GLU 324 n 324 GLU 324 A ALA 325 n 325 ALA 325 A PRO 326 n 326 PRO 326 A LEU 327 n 327 LEU 327 A LYS 328 n 328 LYS 328 A LEU 329 n 329 LEU 329 A SER 330 n 330 SER 330 A LYS 331 n 331 LYS 331 A ALA 332 n 332 ALA 332 A VAL 333 n 333 VAL 333 A HIS 334 n 334 HIS 334 A LYS 335 n 335 LYS 335 A ALA 336 n 336 ALA 336 A VAL 337 n 337 VAL 337 A LEU 338 n 338 LEU 338 A THR 339 n 339 THR 339 A ILE 340 n 340 ILE 340 A ASP 341 n 341 ASP 341 A GLU 342 n 342 GLU 342 A LYS 343 n 343 LYS 343 A GLY 344 n 344 GLY 344 A THR 345 n 345 THR 345 A GLU 346 n 346 GLU 346 A ALA 347 n 347 ALA 347 A ALA 348 n 348 ALA 348 A GLY 349 n 349 GLY 349 A ALA 350 n 350 ALA 350 A MET 351 n 351 MET 351 A PHE 352 n 352 PHE 352 A LEU 353 n 353 LEU 353 A GLU 354 n 354 GLU 354 A ALA 355 n 355 ALA 355 A ILE 356 n 356 ILE 356 A PRO 357 n 357 PRO 357 A MET 358 n 358 MET 358 A SER 359 n 359 SER 359 A ILE 360 n 360 ILE 360 A PRO 361 n 361 PRO 361 A PRO 362 n 362 PRO 362 A GLU 363 n 363 GLU 363 A VAL 364 n 364 VAL 364 A LYS 365 n 365 LYS 365 A PHE 366 n 366 PHE 366 A ASN 367 n 367 ASN 367 A LYS 368 n 368 LYS 368 A PRO 369 n 369 PRO 369 A PHE 370 n 370 PHE 370 A VAL 371 n 371 VAL 371 A PHE 372 n 372 PHE 372 A LEU 373 n 373 LEU 373 A MET 374 n 374 MET 374 A ILE 375 n 375 ILE 375 A GLU 376 n 376 GLU 376 A GLN 377 n 377 GLN 377 A ASN 378 n 378 ASN 378 A THR 379 n 379 THR 379 A LYS 380 n 380 LYS 380 A SER 381 n 381 SER 381 A PRO 382 n 382 PRO 382 A LEU 383 n 383 LEU 383 A PHE 384 n 384 PHE 384 A MET 385 n 385 MET 385 A GLY 386 n 386 GLY 386 A LYS 387 n 387 LYS 387 A VAL 388 n 388 VAL 388 A VAL 389 n 389 VAL 389 A ASN 390 n 390 ASN 390 A PRO 391 n 391 PRO 391 A THR 392 n 392 THR 392 A GLN 393 n 393 GLN 393 A LYS 394 n 394 LYS 394 A author_defined_assembly 1 monomeric A SCS 232 3-(ETHYLDISULFANYL)-L-ALANINE A SCS 232 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 50 A O ILE 50 A N LYS 387 A N LYS 387 A O LEU 383 A O LEU 383 A N MET 374 A N MET 374 A O VAL 371 A O VAL 371 A N PHE 253 A N PHE 253 A O ALA 250 A O ALA 250 A N MET 242 A N MET 242 A O GLU 141 A O GLU 141 A N LEU 118 A N LEU 118 A O THR 113 A O THR 113 A N PHE 189 A N PHE 189 A O LEU 184 A O LEU 184 A N LYS 331 A N LYS 331 A O HIS 334 A O HIS 334 A N TYR 297 A N TYR 297 A O GLU 204 A O GLU 204 A N MET 220 A N MET 220 A O MET 221 A O MET 221 A N LEU 288 A N LEU 288 A O SER 285 A O SER 285 A N PRO 362 A N PRO 362 1 A MET 1 A MET 1 1 Y 1 A ASP 2 A ASP 2 1 Y 1 A PRO 3 A PRO 3 1 Y 1 A GLN 4 A GLN 4 1 Y 1 A GLY 5 A GLY 5 1 Y 1 A ASP 6 A ASP 6 1 Y 1 A ALA 7 A ALA 7 1 Y 1 A ALA 8 A ALA 8 1 Y 1 A GLN 9 A GLN 9 1 Y 1 A LYS 10 A LYS 10 1 Y 1 A THR 11 A THR 11 1 Y 1 A ASP 12 A ASP 12 1 Y 1 A THR 13 A THR 13 1 Y 1 A SER 14 A SER 14 1 Y 1 A HIS 15 A HIS 15 1 Y 1 A HIS 16 A HIS 16 1 Y 1 A ASP 17 A ASP 17 1 Y 1 A GLN 18 A GLN 18 1 Y 1 A ASP 19 A ASP 19 1 Y 1 A HIS 20 A HIS 20 1 Y 1 A PRO 21 A PRO 21 1 Y 1 A THR 22 A THR 22 1 Y 1 A PRO 106 A PRO 106 0 Y 1 A ASP 107 A ASP 107 0 Y 1 A SER 108 A SER 108 0 Y 1 A LYS 25 -146.43 -50.65 1 A GLN 44 -45.42 -73.77 1 A SER 47 -115.51 56.24 1 A ALA 70 47.92 -146.37 1 A PRO 106 -63.73 -155.45 1 A SER 108 165.45 142.12 1 A GLN 111 -56.90 105.96 1 A LYS 136 -68.35 -77.48 1 A HIS 139 39.74 41.83 1 A ASP 149 -106.37 78.64 1 A ASP 171 34.99 69.49 1 A LYS 191 -163.49 76.34 1 A HIS 209 -67.35 99.14 1 A ASN 247 -165.51 28.20 1 A ASP 256 -63.27 -176.72 1 A LEU 318 -109.36 45.00 1 A ASP 341 -147.58 -157.85 1 A LYS 343 169.67 98.86 1 A ALA 347 -149.07 -158.26 1 A ALA 348 -53.91 87.83 1 A ALA 350 56.59 100.94 1 A SER 359 -179.15 140.22 1 A ILE 360 -53.90 101.97 RESIDUES 106 - 108 ARE POORLY ORDERED. ALTHOUGH SOME CONNECTED DENSITY EXISTS, A STEREOCHEMICALLY CORRECT MODEL FITTING THE DATA COULD NOT BE BUILT. THE OCCUPANCIES OF THESE RESIDUES ARE SET TO ZERO. PRO 106 - SER 108 IS A POORLY ORDERED LOOP, PRESENT IN MULTIPLE CONFORMATIONS. A STEREOCHEMICALLY VALID MODEL WAS BUILT, BUT THE OCCUPANCIES ARE SET TO ZERO. 0.288 0.218 0.218 2.92 6.00 6699 91.7 1 0.000 MOLECULAR REPLACEMENT CLEAVED ALPHA1-ANTITRYPSIN (PDB ENTRY 9API) 2.92 6.00 0 2956 0 0 2956 0.005 1.53 15.76 2.920 19.500 1PSI 7651 3.500 0.11400 0.11400 1 8.3600 2.200 91.7 0.204 2.91 3.11 4.000 0.204 2.00 74.4 model building X-PLOR refinement X-PLOR data reduction MOSFLM data scaling CCP4 (SCALA) phasing X-PLOR Intact recombined alpha1-antitrypsin mutant PHE 51 to LEU 1 N N A THR 27 A THR 27 HELX_P A GLN 44 A GLN 44 1 1 18 A PRO 54 A PRO 54 HELX_P A GLY 67 A GLY 67 1 2 14 A ALA 70 A ALA 70 HELX_P A GLY 79 A GLY 79 1 3 10 A GLU 89 A GLU 89 HELX_P A ASN 104 A ASN 104 1 4 16 A ASP 128 A ASP 128 HELX_P A LYS 135 A LYS 135 1 5 8 A THR 150 A THR 150 HELX_P A GLY 164 A GLY 164 1 6 15 A VAL 200 A VAL 200 HELX_P A ASP 202 A ASP 202 5 7 3 A LEU 260 A LEU 260 HELX_P A GLU 266 A GLU 266 1 8 7 A HIS 269 A HIS 269 HELX_P A LEU 276 A LEU 276 1 9 8 A LEU 299 A LEU 299 HELX_P A GLN 305 A GLN 305 1 10 7 A LYS 310 A LYS 310 HELX_P A PHE 312 A PHE 312 5 11 3 covale 1.323 both A HIS 231 A C HIS 231 1_555 A SCS 232 A N SCS 232 1_555 covale 1.325 both A SCS 232 A C SCS 232 1_555 A LYS 233 A N LYS 233 1_555 SERINE PROTEASE INHIBITOR SERPIN, SERINE PROTEASE INHIBITOR, GLYCOPROTEIN, POLYMORPHISM, EMPHYSEMA, DISEASE MUTATION, ACUTE PHASE A1AT_HUMAN UNP 1 1 P01009 MPSSVSWGILLLAGLCCLVPVSLAEDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVS IATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKK LYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTV KVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGT YDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIE QNTKSPLFMGKVVNPTQK 26 418 1PSI 2 394 P01009 A 1 2 394 1 PHE engineered mutation LEU 51 1PSI A P01009 UNP 75 51 5 5 4 anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel parallel A ILE 50 A ILE 50 A PHE 52 A PHE 52 A PRO 382 A PRO 382 A VAL 388 A VAL 388 A PHE 370 A PHE 370 A GLU 376 A GLU 376 A ALA 248 A ALA 248 A PRO 255 A PRO 255 A SER 237 A SER 237 A LYS 243 A LYS 243 A GLU 141 A GLU 141 A VAL 145 A VAL 145 A LEU 112 A LEU 112 A SER 121 A SER 121 A PHE 182 A PHE 182 A PHE 190 A PHE 190 A LYS 331 A LYS 331 A ILE 340 A ILE 340 A LEU 291 A LEU 291 A ASP 298 A ASP 298 A GLU 204 A GLU 204 A HIS 209 A HIS 209 A THR 215 A THR 215 A PHE 227 A PHE 227 A ARG 282 A ARG 282 A PRO 289 A PRO 289 A PRO 362 A PRO 362 A PHE 366 A PHE 366 5 C 1 2 1